Innovent Biologics, Inc. announced the appointment of Dr. Yong Jun Liu, a renowned world class scientist and successful leader in biopharmaceutical industry, as the president of the group. Reporting to Dr. Michael Yu, founder, chairman and CEO of the group, Dr. Liu will be mainly responsible for group's global R&D, portfolio strategy, business development as well as international operation. As a world renowned scientist in immunology, oncology and translational medicine, Dr. Liu has over 30 years' experiences in both academic institutions and top global pharmaceutical companies.